Cargando…

Usefulness of FDG, MET and FLT-PET Studies for the Management of Human Gliomas

The use of positron imaging agents such as FDG, MET, and FLT is expected to lead the way for novel applications toward efficient malignancy grading and treatment of gliomas. In this study, the usefulness of FDG, MET and FLT-PET images was retrospectively reviewed by comparing their histopathological...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyake, Keisuke, Shinomiya, Aya, Okada, Masaki, Hatakeyama, Tetsuhiro, Kawai, Nobuyuki, Tamiya, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3336213/ https://www.ncbi.nlm.nih.gov/pubmed/22577290 http://dx.doi.org/10.1155/2012/205818

Ejemplares similares

Diagnostic value of PET/CT with (11)C-methionine (MET) and (18)F-fluorothymidine (FLT) in newly diagnosed glioma based on the 2016 WHO classification
por: Ogawa, Tomoya, et al.
Publicado: (2020)

Hypoxia and glucose metabolism assessed by FMISO and FDG PET for predicting IDH1 mutation and 1p/19q codeletion status in newly diagnosed malignant gliomas
por: Suzuki, Kenta, et al.
Publicado: (2021)

Comparison of 4′-[methyl-(11)C]thiothymidine ((11)C-4DST) and 3′-deoxy-3′-[(18)F]fluorothymidine ((18)F-FLT) PET/CT in human brain glioma imaging
por: Toyota, Yasunori, et al.
Publicado: (2015)

Usefulness of Positron Emission Tomographic Studies for Gliomas
por: MIYAKE, Keisuke, et al.
Publicado: (2016)

Diagnostic Value of (11)C-Methionine (MET) and (18)F-Fluorothymidine (FLT) Positron Emission Tomography in Recurrent High-Grade Gliomas; Differentiation from Treatment-Induced Tissue Necrosis
por: Shishido, Hajime, et al.
Publicado: (2012)

NI-15 THE USEFULNESS OF PET IMAGING IN MOLECULAR DIAGNOSIS OF GLIOMA
por: Ogawa, Tomoya, et al.
Publicado: (2019)

Multiple positron emission tomography tracers for use in the classification of gliomas according to the 2016 World Health Organization criteria
por: Miyake, Keisuke, et al.
Publicado: (2020)

(18)F-FDG PET in the Diagnosis and Treatment of Primary Central Nervous System Lymphoma
por: Kawai, Nobuyuki, et al.
Publicado: (2013)

STMO-15 OUR THERAPEUTIC STRATEGIES FOR GLIOBLASTOMA: INTRAOPERATIVE SUPPORT SYSTEMS [INTRAOPERATIVE MRI, PET, 5-AMINOLEVULINIC ACID (5-ALA)] AND NEOADJUVANT CHEMOTHERAPY
por: Miyake, Keisuke, et al.
Publicado: (2019)

BIMG-06. RESPONSE ASSESSMENT OF BEVACIZUMAB THERAPY FOR GLIOBLASTOMA BY USING MULTIPLE PET TRACERS
por: Miyake, Keisuke, et al.
Publicado: (2021)

Fractal analysis of (11)C-methionine PET in patients with newly diagnosed glioma
por: Maeda, Yukito, et al.
Publicado: (2021)

Relation of LAT1/4F2hc expression with pathological grade, proliferation and angiogenesis in human gliomas
por: Haining, Zhen, et al.
Publicado: (2012)

Resveratrol represses YKL-40 expression in human glioma U87 cells
por: Zhang, Wei, et al.
Publicado: (2010)

GEN-09 Pursuing the function of microRNA targeting (Pro)renin receptor against glioma
por: Ogawa, Daisuke, et al.
Publicado: (2020)

Correlation of 4′-[methyl-(11)C]-thiothymidine PET with Gd-enhanced and FLAIR MRI in patients with newly diagnosed glioma
por: Norikane, Takashi, et al.
Publicado: (2021)

STMO-5 Utilization of intraoperative multimodal technologies [PET and 5-ALA] for treating glioblastoma
por: Miyake, Keisuke, et al.
Publicado: (2021)

Clinicopathologic Factors Associated with Tumor Necrosis after Preoperative Embolization of Meningiomas
por: Fujimori, Takeshi, et al.
Publicado: (2021)

Glioblastoma Treatment in the Elderly
por: OKADA, Masaki, et al.
Publicado: (2017)

Temporal and spatial changes in reactive astrogliosis examined by (18)F-THK5351 positron emission tomography in a patient with severe traumatic brain injury
por: Hatakeyama, Tetsuhiro, et al.
Publicado: (2021)

Insufficiency of Positron Emission Tomography and Magnetic Resonance Spectroscopy in the Diagnosis of Intravascular Lymphoma of the Central Nervous System
por: Kawai, Nobuyuki, et al.
Publicado: (2012)

NI-08 Utility of multiple positron emission tomography tracers in the diagnosis of brain tumors according to the 2016 World Health Organization classification
por: Miyake, Keisuke, et al.
Publicado: (2020)

IMG-02. USEFUL DIAGNOSIS OF PEDIATRIC CYSTIC BRAIN TUMORS USING MULTIPLE POSITRON EMISSION TOMOGRAPHY STUDIES
por: Miyake, Keisuke, et al.
Publicado: (2020)

FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: a prospective study with comparison to FDG-PET
por: Martineau, Patrick, et al.
Publicado: (2020)

Impact of [(18)F]FDG-PET and [(18)F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer
por: Christensen, Tine N., et al.
Publicado: (2021)

Comparison of [(18)F]FIMP, [(11)C]MET, and [(18)F]FDG PET for early-phase assessment of radiotherapy response
por: Nozaki, Satoshi, et al.
Publicado: (2023)

The Values and Limitations of FDG-PET/CT for Diagnosis of Hibernoma
por: Park, Jong Hoon, et al.
Publicado: (2015)

Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer
por: Rendl, Gundula, et al.
Publicado: (2014)

(18)F-FLT and (18)F-FDG PET/CT in Predicting Response to Chemoradiotherapy in Nasopharyngeal Carcinoma: Preliminary Results
por: Qi, Shi, et al.
Publicado: (2017)

Disseminated Skeletal Muscle and Cardiac Metastasis from Squamous Cell Carcinoma of the Lung Detected with FDG and FLT PET/CT
por: Jain, Tarun Kumar, et al.
Publicado: (2016)

A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB–IIIA resectable NSCLC
por: Crandall, John P., et al.
Publicado: (2017)

FDG-PET in Follicular Lymphoma Management
por: Bodet-Milin, C., et al.
Publicado: (2012)

Prospective comparison of early interim (18)F-FDG-PET with (18)F-FLT-PET for predicting treatment response and survival in metastatic breast cancer
por: Su, Tzu-Pei, et al.
Publicado: (2021)

Imaging of Treatment Response to the Combination of Carboplatin and Paclitaxel in Human Ovarian Cancer Xenograft Tumors in Mice Using FDG and FLT PET
por: Munk Jensen, Mette, et al.
Publicado: (2013)

FDG and FLT-PET for Early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinoma
por: Horn, Kevin P., et al.
Publicado: (2015)

Differences between [(18)F]FLT and [(18)F]FDG Uptake in PET/CT Imaging in CC Depend on Vaginal Bacteriology
por: Burchardt, Ewa, et al.
Publicado: (2021)

A Case of Ewing Sarcoma of the Mandible on (18)F-FDG PET/CT
por: Takami, Yasukage, et al.
Publicado: (2020)

FLT PET-CT in evaluation of treatment response
por: Sanghera, Bal, et al.
Publicado: (2014)

Usefulness of FDG PET/CT in the management of tuberculosis
por: Sánchez-Montalvá, Adrián, et al.
Publicado: (2019)

Clinical utility of FDG-PET/CT for post-surgery surveillance of malignant pleural mesothelioma – Comparison with contrast-enhanced CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2019)

ET-04 MOLECULAR TARGETED THERAPY AGAINST (PRO)RENIN RECEPTOR FOR GLIOBLASTOMA
por: Fujimori, Takeshi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t0smue7gj4ida2p9g9rkpt4p1m